Amanda Cavaleri, a director at $CLSK, sold 33,000 shares of the company on 12-04-2025 for an estimated $495,660. We received data on the trade from a recent SEC filing. This was a sale of approximately 23.5% of their shares of this class of stock. Following this trade, they now own 107,289 shares of this class of $CLSK stock.
$CLSK Insider Trading Activity
$CLSK insiders have traded $CLSK stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $CLSK stock by insiders over the last 6 months:
- TAYLOR MONNIG (CTO, COO) sold 63,713 shares for an estimated $581,062
- AMANDA CAVALERI sold 33,000 shares for an estimated $495,660
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CLSK Hedge Fund Activity
We have seen 189 institutional investors add shares of $CLSK stock to their portfolio, and 172 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MORGAN STANLEY removed 4,183,354 shares (-39.8%) from their portfolio in Q3 2025, for an estimated $60,658,633
- VOLORIDGE INVESTMENT MANAGEMENT, LLC added 3,865,946 shares (+inf%) to their portfolio in Q3 2025, for an estimated $56,056,217
- D. E. SHAW & CO., INC. added 3,559,228 shares (+inf%) to their portfolio in Q3 2025, for an estimated $51,608,806
- BERYL CAPITAL MANAGEMENT LLC added 2,023,507 shares (+inf%) to their portfolio in Q3 2025, for an estimated $29,340,851
- POINT72 ASSET MANAGEMENT, L.P. added 1,955,212 shares (+inf%) to their portfolio in Q3 2025, for an estimated $28,350,574
- DIMENSIONAL FUND ADVISORS LP added 1,564,761 shares (+57.0%) to their portfolio in Q3 2025, for an estimated $22,689,034
- TUDOR INVESTMENT CORP ET AL added 1,424,439 shares (+462.7%) to their portfolio in Q3 2025, for an estimated $20,654,365
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CLSK Revenue
$CLSK had revenues of $223.7M in Q4 2025. This is an increase of 150.52% from the same period in the prior year.
You can track CLSK financials on Quiver Quantitative's CLSK stock page.
$CLSK Analyst Ratings
Wall Street analysts have issued reports on $CLSK in the last several months. We have seen 10 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- B. Riley Securities issued a "Buy" rating on 11/26/2025
- Needham issued a "Buy" rating on 11/26/2025
- Macquarie issued a "Outperform" rating on 11/26/2025
- HC Wainwright & Co. issued a "Buy" rating on 11/26/2025
- Chardan Capital issued a "Buy" rating on 11/26/2025
- JP Morgan issued a "Overweight" rating on 11/24/2025
- Bernstein issued a "Outperform" rating on 11/03/2025
To track analyst ratings and price targets for $CLSK, check out Quiver Quantitative's $CLSK forecast page.
$CLSK Price Targets
Multiple analysts have issued price targets for $CLSK recently. We have seen 10 analysts offer price targets for $CLSK in the last 6 months, with a median target of $24.5.
Here are some recent targets:
- Nick Giles from B. Riley Securities set a target price of $22.0 on 11/26/2025
- Paul Golding from Macquarie set a target price of $27.0 on 11/26/2025
- James McIlree from Chardan Capital set a target price of $30.0 on 11/26/2025
- John Todaro from Needham set a target price of $25.0 on 11/26/2025
- Mike Colonnese from HC Wainwright & Co. set a target price of $27.0 on 11/26/2025
- Reginald Smith from JP Morgan set a target price of $14.0 on 11/24/2025
- Brett Knoblauch from Cantor Fitzgerald set a target price of $23.0 on 11/05/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
